FT
Fortrea Holdings Inc. (FTRE)
NASDAQ·Healthcare·Biotechnology
$22.25
+1.82%
Mkt Cap $1.89B
Analyst Ratings
Buy
11
Hold
4
Sell
0
Price Target (36 analysts)
$20.50
Range $16.00 – $23.00
Implied Upside
-7.9%
Consensus $20.50 vs current $22.25
NASDAQ·Healthcare·Biotechnology
$22.25
+1.82%
Mkt Cap $1.89B
Buy
11
Hold
4
Sell
0
Price Target (36 analysts)
$20.50
Range $16.00 – $23.00
-7.9%
Consensus $20.50 vs current $22.25